Reduced Haloperidol

SKU: orb1693104

Description

Reduced haloperidol is the active metabolite of haloperidol, formed by ketone reductase. It acts as a sigma-1 and dopamine D2 receptor antagonist, inhibits monoamine reuptake, and stimulates BDNF secretion in vitro. In vivo, it demonstrates analgesic effects in specific mouse models of chemical hypersensitivity.

Research Area

Metabolism Research, Pharmacology & Drug Discovery

Images & Validation

−

Key Properties

−

CAS Number	34104-67-1
MW	377.88
Formula	C₂₁H₂₅ClFNO₂
SMILES	OC(CCCN1CCC(O)(CC1)c1ccc(Cl)cc1)c1ccc(F)cc1
Target	Drug Metabolite,Others

Storage & Handling

−

Storage	-20°C
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Compound Identifiers

PubChem CID

119265 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols